Warning letter
Soluble Products Co., LP [ARCHIVED]: warning letter of Mar 25, 2011
FDA warning letter 130630 · New Jersey District Office
Key facts
| Reference number | 130630 |
|---|---|
| Company | Soluble Products Co., LP [ARCHIVED] |
| Subject | CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated |
| Issue date | Mar 25, 2011 |
| Posted date | Mar 25, 2011 |
| Issuing office | New Jersey District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111, 111.70(b)(1), 111.70(f), 111.75(a)(2)(ii), 111.83(b)(3), 111.210(h)(1), 111.75(a)(2), 111.75(c) |
| Inspection city | Lakewood |
| Inspection ZIP | 08701 |
| Inspection start date | Aug 2, 2010 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: